centigray.com - November 2005

Case Presentations

Adenocarcinoma of the right lung and the impact of high-dose IGRT

November 2005

PDF

Print

E-mail

Ma L, Kwok Y, Chin LS, Yu C, Regine WF.
Comparative analyses of linac and Gamma Knife radiosurgery for trigeminal neuralgia treatments. Phys Med Biol. 2005 Nov 21;50(22):5217-27.

Kondziolka D, Martin JJ, Flickinger JC, Friedland DM, Brufsky AM, Baar J, Agarwala S, Kirkwood JM, Lunsford LD.
Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer. 2005 Nov 15;

Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D.
Stereotactic radiosurgery (for glioma). Cancer. 2005 Nov 15;104(10):2168-73.

Gerszten PC, Burton SA, Welch WC, Brufsky AM, Lembersky BC, Ozhasoglu C, Vogel WJ.
Single-fraction radiosurgery for the treatment of spinal breast metastases. Cancer. 2005 Nov 15;104(10):2244-54.

Kupelian PA, Ramsey C, Meeks SL, Willoughby TR, Forbes A, Wagner TH, Langen KM.
Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: Observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1024-8.

Laack NN, Brown PD, Ivnik RJ, Furth AF, Ballman KV, Hammack JE, Arusell RM, Shaw EG, Buckner JC.
Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1175-83.

Ritoe SC, Bergman H, Krabbe PF, Kaanders JH, van den Hoogen FJ, Verbeek AL, Marres HA.
Cancer recurrence after total laryngectomy: Treatment options, survival, and complications. Head Neck. 2005 Nov 14;

Rabinovitch R, Grant B, Berkey BA, Raben D, Ang KK, Fu KK, Cooper JS.
Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: A secondary analysis of RTOG trial 90-03. Head Neck. 2005 Nov 14;

Stephenson AJ, Eastham JA.
Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol. 2005 Nov 10;23(32):8198-203.

Hitt R, Lopez-Pousa A, Martinez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Marti JL, Lobo F, Pastor P, Valenti V, Belon J, Sanchez MA, Chaib C, Pallares C, Anton A, Cervantes A, Paz-Ares L, Cortes-Funes H.
Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer. J Clin Oncol. 2005 Nov 7;

Hashine K, Numata K, Azuma K, Sumiyoshi Y, Kataoka M.
Long-Term Outcomes of 60 Gy Conventional Radiotherapy Combined with Androgen Deprivation for Localized or Locally Advanced Prostate Cancer. Jpn J Clin Oncol. 2005 Nov 7;

Christian JA, Partridge M, Nioutsikou E, Cook G, McNair HA, Cronin B, Courbon F, Bedford JL, Brada M.
The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer. Radiother Oncol. 2005 Nov 3;

Christie D, Denham J, Steigler A, Lamb D, Turner S, Mameghan H, Joseph D, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Spry NA, Tai KH, Wynne C, Duchesne G, Kovacev O, Francis L, Kramar A, D'Este C, Bill D.
Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation. Radiother Oncol. 2005 Nov 3;

Pinkawa M, Fischedick K, Treusacher P, Asadpour B, Gagel B, Piroth MD, Borchers H, Jakse G, Eble MJ.
Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer- a phase II study. Radiother Oncol. 2005 Nov 3;

Aoki M, Abe Y, Hatayama Y, Kondo H, Basaki K.
Clinical outcome of hypofractionated conventional conformation radiotherapy for patients with single and no more than three metastatic brain tumors, with noninvasive fixation of the skull without whole brain irradiation. Int J Radiat Oncol Biol Phys. 2005 Nov 2;

Goldner G, Zimmermann F, Feldmann H, Glocker S, Wachter-Gerstner N, Geinitz H, Becker G, Potzi R, Wambersie A, Bamberg M, Molls M, Wachter S, Potter R.
3-D conformal radiotherapy of localized prostate cancer: A subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects. Radiother Oncol. 2005 Nov 2;

Mansur DB, Kong FM, El Naqa I, Taylor ME, Zoberi I, Bradley JD, Perez CA, Klein EE.
CT localization of axillary lymph nodes in relation to the humeral head: Significance of arm position for radiation therapy planning. Radiother Oncol. 2005 Nov 2;

Pipas JM, Barth RJ Jr, Zaki B, Tsapakos MJ, Suriawinata AA, Bettmann MA, Cates JM, Ripple GH, Sutton JE, Gordon SR, McDonnell CE, Perez RP, Redfield N, Meyer LP, Marshall JF, Cole BF, Colacchio TA.
Docetaxel/Gemcitabine Followed by Gemcitabine and External Beam Radiotherapy in Patients With Pancreatic Adenocarcinoma. Ann Surg Oncol. 2005 Nov 1;

Menes TS, Tartter PI, Bleiweiss I, Godbold JH, Estabrook A, Smith SR.
The consequence of multiple re-excisions to obtain clear lumpectomy margins in breast cancer patients. Ann Surg Oncol. 2005 Nov;12(11):881-5. Epub 2005 Oct 3.

Terai A, Matsui Y, Yoshimura K, Arai Y, Dodo Y.
Salvage radiotherapy for biochemical recurrence after radical prostatectomy. BJU Int. 2005 Nov;96(7):1009-13.

Rapp DE, Orvieto MA, Lucioni A, Gong EM, Shalhav AL, Brendler CB.
Intra-operative prostate examination: predictive value and effect on margin status. BJU Int. 2005 Nov;96(7):1005-8.

Richtig E, Ludwig R, Kerl H, Smolle J.
Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma. Br J Dermatol. 2005 Nov;153(5):925-31.

Kuo SJ, Yang KT, Chen DR.
Objective and noninvasive detection of sub-clinical lung injury in breast cancer patients after radiotherapy. Eur J Surg Oncol. 2005 Nov;31(9):954-7.

Lin K, Patel SG, Chu PY, Matsuo JM, Singh B, Wong RJ, Kraus DH, Shaha AR, Shah JP, Boyle JO.
Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck. 2005 Nov 1;27(12):1042-1048

Berthelet E, Pickles T, Lee KW, Liu M, Truong PT; Prostate Cancer Outcomes Initiative.
Long-term androgen deprivation therapy improves survival in prostate cancer patients presenting with prostate-specific antigen levels >20 ng/mL. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):781-7.

Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D.
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):795-9. Epub 2005 May 31.

Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z.
Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):765-71.

Lester JF, Macbeth FR, Coles B.
Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: A Cochrane Review. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):690-4.

Kaufmann M, Graf E, Jonat W, Eiermann W, Geberth M, Albert US, Gademann G, Conrad B, Stahl K, von Minckwitz G, Schumacher M; German Adjuvant Breast Cancer Group.
Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group. J Clin Oncol. 2005 Nov 1;23(31):7842-8.

Park S, Meng MV, Elkin EP, Speight JL, DuChane J, Carroll PR.
Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE. J Urol. 2005 Nov;174(5):1802-7.

Denham JW, Steigler A, Lamb DS, Joseph D, Mameghan H, Turner S, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Christie D, Spry NA, Tai KH, Wynne C, Duchesne G, Kovacev O, D'Este C.
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncol. 2005 Nov;6(11):841-50.

Ruffer JU, Ballova V, Glossmann J, Sieber M, Franklin J, Nogova L, Diehl V, Josting A.
BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - Results of the German Hodgkin Study Group. Leuk Lymphoma. 2005 Nov;46(11):1561-7.

Metellus P, Regis J, Muracciole X, Fuentes S, Dufour H, Nanni I, Chinot O, Martin PM, Grisoli F.
Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy. Neurosurgery. 2005 Nov;57(5):873-86; discussion 873-86.

Poetker DM, Jursinic PA, Runge-Samuelson CL, Wackym PA.
Distortion of Magnetic Resonance Images Used in Gamma Knife Radiosurgery Treatment Planning: Implications for Acoustic Neuroma Outcomes. Otol Neurotol. 2005 Nov;26(6):1220-1228.

Iwai Y, Yamanaka K, Yoshimura M.
Gamma knife radiosurgery for cavernous sinus metastases and invasion. Surg Neurol. 2005 Nov;64(5):406-10.

Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ.
Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology. 2005 Nov;66(5):1060-5.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Adamovich E.
Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy. Urology. 2005 Nov;66(5):1048-53.

Pelzer AE, Tewari A, Bektic J, Berger AP, Frauscher F, Bartsch G, Horninger W.
Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project. Urology. 2005 Nov;66(5):1029-33.

Dvorak T, Chen MH, Renshaw AA, Loffredo M, Richie JP, D'Amico AV.
Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer. Urology. 2005 Nov;66(5):1024-8.

Beard C, Chen MH, Cote K, Loffredo M, Renshaw A, Hurwitz M, D'Amico AV.
Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer. Urology. 2005 Nov;66(5):1020-3.

Rubin MA, Allory Y, Molinie V, Leroy X, Faucon H, Vacherot F, Huang W, Kuten A, Salomon L, Rebillard X, Cussenot O, Abbou C, de la Taille A.
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome. Urology. 2005 Nov;66(5):930-4.

Menon M, Shrivastava A, Tewari A.
Laparoscopic radical prostatectomy: conventional and robotic. Urology. 2005 Nov;66(5 Suppl):101-4.

Dussinger AM, Beck SD, Cheng L, Koch MO.
Does wide primary perirectal dissection during radical retropubic prostatectomy alter pathologic and biochemical outcomes? Urology. 2005 Nov;66(5 Suppl):95-100.